Literature DB >> 1943886

Serum amyloid A (SAA), a protein without a function: some suggestions with reference to cholesterol metabolism.

R Kisilevsky1.   

Abstract

Serum amyloid A, as an apolipoprotein, is present on high density lipoprotein only during inflammatory states. When viewed from HDL's established function as a mechanism for reverse cholesterol transportation, it is postulated that serum amyloid A represents a signal to redirect HDL to sites of tissue destruction where cholesterol is being collected by macrophages. The object is to direct the reverse cholesterol transporter to sites of cholesterol accumulation for the subsequent removal of these cholesterol stores. The hypothesis has relevance to the process of atheroma formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1943886     DOI: 10.1016/0306-9877(91)90280-c

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  10 in total

1.  SAA: a link between cholesterol efflux capacity and inflammation?

Authors:  Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Lipid Res       Date:  2015-06-15       Impact factor: 5.922

2.  NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

Authors:  J C Pickup; M B Mattock; G D Chusney; D Burt
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

3.  Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury.

Authors:  Ni Cheng; Yurong Liang; Xiaoping Du; Richard D Ye
Journal:  EMBO Rep       Date:  2018-08-20       Impact factor: 8.807

Review 4.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

5.  Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters.

Authors:  I Hardardóttir; S T Kunitake; A H Moser; W T Doerrler; J H Rapp; C Grünfeld; K R Feingold
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

6.  Comparison of serum phospholipase A2, polymorphonuclear granulocyte elastase, C-reactive protein and serum amyloid A with the APACHE II score in the prognosis of multiple injured patients.

Authors:  R Ensenauer; M Püttmann; M Quintel; R Kattermann; J Aufenanger
Journal:  Clin Investig       Date:  1994-11

Review 7.  Serum amyloid A1: Structure, function and gene polymorphism.

Authors:  Lei Sun; Richard D Ye
Journal:  Gene       Date:  2016-03-03       Impact factor: 3.688

8.  Apolipoprotein AI-derived pulmonary vascular amyloid in aged dogs.

Authors:  K E Roertgen; E M Lund; T D O'Brien; P Westermark; D W Hayden; K H Johnson
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

9.  A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells.

Authors:  S B Su; W Gong; J L Gao; W Shen; P M Murphy; J J Oppenheim; J M Wang
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

10.  Does the Urothelium of Old Mice Regenerate after Chitosan Injury as Quickly as the Urothelium of Young Mice?

Authors:  Eva Erzar; Mojca Kerec Kos; Katja Lakota; Peter Veranič; Andreja Erman
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.